Brown adipose tissue-derived exosomes mitigate the metabolic syndrome in high fat diet mice

• Published in: Theranostics Vol. 10; no. 18; pp. 8197 - 8210
• Main Authors: Zhou, Xueying, Li, Zhelong, Qi, Meihao, Zhao, Ping, Duan, Yunyou, Yang, Guodong, Yuan, Lijun
• Format: Journal Article
• Language: English
• Published: Australia Ivyspring International Publisher Pty Ltd 01.01.2020; Ivyspring International Publisher
• Subjects: Adipocytes; Adipose Tissue, Brown - cytology; Animals; Body fat; Body Weight; Cardiac function; Cholesterol; Diet, High-Fat - adverse effects; Disease Models, Animal; Energy; Energy Metabolism; Exosomes - metabolism; Exosomes - ultrastructure; Glucose; Heart; Histology; Intravital Microscopy; Lipids; Liver; Male; Metabolic disorders; Metabolic Syndrome - etiology; Metabolic Syndrome - metabolism; Mice; Mitochondria - metabolism; Mitochondria - ultrastructure; Obesity; Optical Imaging; Refractory Period, Electrophysiological; Research Paper; cardiovascular diseases; brown adipose tissue; Exosomes; cell-free therapy; obesity
• ISSN: 1838-7640; 1838-7640
• DOI: 10.7150/thno.43968

The ever-increasing incidence of obesity and related disorders impose serious challenges on public health worldwide. Brown adipose tissue (BAT) has strong capacity for promoting energy expenditure and has shown great potential in treating obesity. Exosomes are nanovesicles that share the characteristics of their donor cells. Whether BAT derived exosomes (BAT-Exos) might exert similar metabolic benefits on obesity is worthy of investigation. Obese mice were established by high-fat-diet (HFD) feeding and were treated with Seum-Exos or BAT-Exos isolated from young healthy mice. Blood glucose, glucose tolerance and blood lipids were tested in mice with indicated treatments. Histology examinations were performed on adipose tissue, liver and heart by HE staining and/or Oil Red O staining. Echocardiography was performed to evaluate cardiac function of mice. distribution of exosomes was analyzed by fluorescence labeling and imaging and effects of exosomes were evaluated by cell metabolism analysis. Protein contents of BAT-Exos were analyzed by mass spectrometry. The results showed that BAT-Exos reduced the body weight, lowered blood glucose and alleviated lipid accumulation in HFD mice independently of food intake. Echocardiography revealed that the abnormal cardiac functions of HFD mice were significantly restored after treatment with BAT-Exos. Cell metabolism analysis showed that treatment with BAT-Exos significantly promoted oxygen consumption in recipient cells. Protein profiling of exosomes demonstrated that BAT-Exos were rich in mitochondria components and involved in catalytic processes. Collectively, our study showed that BAT-Exos significantly mitigated the metabolic syndrome in HFD mice. Detailed elucidation of the reactive molecules and mechanism of action would provide new insights in combating obesity and related disorders.